Biologics Consulting, currently experiencing a season of growth, retained The Chase Group to build out their leadership team. Tasked with identifying a Regulatory Project Management…
Continue Reading →
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company…
Continue Reading →
Checkmate Pharmaceuticals has once again partnered with The Chase Group to continue building its team of life sciences entrepreneurs who are devoted to discovering and…
Continue Reading →
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
Continue Reading →
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Continue Reading →
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical…
Continue Reading →
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
Continue Reading →
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
Continue Reading →
The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of…
Continue Reading →
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Continue Reading →